Product Benefits:

• Dual Mechanism: Combines an SGLT2 inhibitor (Empagliflozin) to remove sugar via urine and Metformin to reduce sugar production in the liver.

• Heart Protection: Helps reduce the risk of cardiovascular death in patients with Type 2 diabetes and established heart disease.

• Weight Management: Empagliflozin can lead to modest weight loss and help manage body mass index (BMI).

• Kidney Support: Provides protective benefits for the kidneys in diabetic patients.

• Better Compliance: Combines two medications into one tablet, making it easier to follow a daily treatment schedule.